effectiveness Of Homoeopathic Treatment For Polycystic ovarian disease in Age Group Of 11-18 Years

A Prospective Single Arm Study on the Effectiveness of Homoeopathic Treatment in Polycystic Ovarian Disease in the Age Group of 11 to 18 Years Using the Modified Naranjo Criteria. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112424

Enrollment

Registered

2026-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Individualized Homoeopathic Medicine: Patients will receive individualized homoeopathic treatment in dosage of 3-5 globules per day, frequency of 3 days in a duration of 12 months. Cont

Eligibility

Inclusion criteria

Inclusion criteria: Age group:11 to 18 years Diagnosed with PCOD Willing to receive only homoeopathic treatment. Patients who expressed their willingness to participate in the study through signed consent form.

Exclusion criteria

Exclusion criteria: Hormone replacement therapy.

Design outcomes

Primary

Measure	Time frame
Change in Modified Naranjo Criteria score and overall clinical improvement in patients with PCOD receiving individualized homoeopathic treatment.Timepoint: Baseline, 9 months, and 18 months after initiation of treatment	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr K Rajani Chander

JSPS Government Homoeopathic Medical College

drkrchander@gmail.com9440051106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026